CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 107 enrolled
Drug / intervention
Hypofractionated Radiation Therapy +2 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03324802
NCT03324802Phase 3Completed

A Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast Alone After Breast Conserving Surgery

Mayo Clinic·interventional·Posted Oct 30, 2017·Updated May 2, 2024

In Brief

A Phase 3 clinical trial evaluating Hypofractionated Radiation Therapy, Quality-of-Life Assessment, and 1 other intervention for Stage I Breast Cancer AJCC v7 and 6 related conditions. Completed, enrolled 107 participants across 3 sites.

Detailed Summary

This randomized phase III trial studies how well hypofractionated radiation therapy works in preventing the return of tumor cells in breast cancer patients following surgery. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.

Study Details

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedOct 30, 2017
Enrollment StartFeb 7, 2018
Primary CompletionJan 31, 2022
Study CompletionAug 28, 2023
TodayJul 2, 2026
Enrollment to primary: 4.0 yearsPosted 8.7 years ago

Interventions

Hypofractionated Radiation Therapyradiation

Undergo hypofractionated radiation therapy

Quality-of-Life Assessmentother

Ancillary studies

Radiation Therapyradiation

hypofractionated radiation therapy